Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.42 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.42 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.40 |
| ▸ | AR | P10275 | 2/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.37 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | XPO1 | O14980 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17700260 | 0.82 | CYP3A4 (0.43) | CYP3A4CYP2C9SLC22A6SLC22A8SLC22A12 | |
| SCHEMBL11901065 | 0.81 | CYP3A4 (0.42) | CYP3A4CYP2C9SLC22A6SLC22A8SLC22A12 | |
| SCHEMBL17700603 | 0.81 | CYP3A4 (0.42) | CYP3A4CYP2C9SLC22A6SLC22A8SLC22A12 | |
| SCHEMBL30401549 | 0.81 | CYP3A4 (0.40) | CYP3A4CYP2C9SLC22A6SLC22A8SLC22A12 | |
| SCHEMBL7665646 | 0.79 | CYP3A4 (0.45) | CYP3A4CYP2C9SLC22A6SLC22A8SLC22A12 | |
| SCHEMBL4966922 | 0.78 | TRPA1 (0.53) | TRPA1PTPN5XPO1 | |
| Hydrochloric Acid SCHEMBL28527606 | 0.77 | CYP3A4 (0.44) | CYP3A4CYP2C9SLC22A6SLC22A8SLC22A12 | |
| SCHEMBL30137071 | 0.76 | SLC22A12 (0.55) | CYP3A4CYP2C9SLC22A6SLC22A8SLC22A12 | |
| SCHEMBL29873215 | 0.76 | L3MBTL1 (0.45) | CYP3A4CYP2C9SLC22A6SLC22A8SLC22A12 | |
| Propionic Acid SCHEMBL28228814 | 0.75 | TAS2R14 (0.44) | CYP3A4CYP2C9SLC22A6SLC22A8SLC22A12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230109839-A1 | THERAPEUTIC AGENT FOR TAUOPATHIES | Sumitomo Pharma Co., Ltd. (JP) | 2023-04-13 | — | — | US | disclosed |
| EP-4104861-A1 | THERAPEUTIC AGENT FOR TAUOPATHIES | Sumitomo Pharma Co., Ltd. (JP) | 2022-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230109839-A1 | THERAPEUTIC AGENT FOR TAUOPATHIES | MAPT, PSEN1, PSEN2 | CYP3A4 4734/4885CYP2C9 4840/4885SLC22A6 792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.